Memorandum of Understanding COVID-19 Consortium
Thu, 09 Apr 2020 09:14:00 GMT
Omega (AIM: ODX), the medical diagnostics company focused on CD4, food intolerance and allergy testing announces that it has signed a Memorandum of Understanding (“MOU”) with three other companies from across the UK, in conjunction with the University of Oxford to form the UK Rapid Test Consortium (“UK-RTC”) in order to jointly develop and manufacture a COVID-19 Point of Care antibody test as part of the Government’s five pillar national testing strategy for COVID-19. Read more here: http://www.omegadiagnostics.com/Portals/0/RNS%20MOU%20on%20COVID-19%20Consortium.pdf
Comments are closed for this post, but if you have spotted an error or have additional info that you think should be in this post, feel free to contact us.